346 related articles for article (PubMed ID: 16391261)
21. Management of children with ambulatory cerebral palsy: an evidence-based review.
Narayanan UG
J Pediatr Orthop; 2012 Sep; 32 Suppl 2():S172-81. PubMed ID: 22890458
[TBL] [Abstract][Full Text] [Related]
22. Results of treatment when orthopaedic surgeons follow gait-analysis recommendations in children with CP.
Lofterød B; Terjesen T
Dev Med Child Neurol; 2008 Jul; 50(7):503-9. PubMed ID: 18611199
[TBL] [Abstract][Full Text] [Related]
23. Effect of botulinum toxin type A treatment in children with cerebral palsy: Sequential physical changes for 3 months after the injection.
Matsuda M; Tomita K; Yozu A; Nakayama T; Nakayama J; Ohguro H; Iwasaki N
Brain Dev; 2018 Jun; 40(6):452-457. PubMed ID: 29510955
[TBL] [Abstract][Full Text] [Related]
24. Botulinum toxin with and without casting in ambulant children with spastic diplegia: a clinical and functional assessment.
Bottos M; Benedetti MG; Salucci P; Gasparroni V; Giannini S
Dev Med Child Neurol; 2003 Nov; 45(11):758-62. PubMed ID: 14580131
[TBL] [Abstract][Full Text] [Related]
25. Effects of different dilutions of botulinum toxin type A treatment for children with cerebral palsy with spastic ankle plantarflexor: a randomized controlled trial.
Lee JH; Sung IY; Yoo JY; Park EH; Park SR
J Rehabil Med; 2009 Sep; 41(9):740-5. PubMed ID: 19774308
[TBL] [Abstract][Full Text] [Related]
26. Muscle synergies demonstrate only minimal changes after treatment in cerebral palsy.
Shuman BR; Goudriaan M; Desloovere K; Schwartz MH; Steele KM
J Neuroeng Rehabil; 2019 Mar; 16(1):46. PubMed ID: 30925882
[TBL] [Abstract][Full Text] [Related]
27. Postoperative gait velocity and mean knee flexion in stance of ambulatory children with spastic diplegia four years or more after multilevel surgery.
Gannotti ME; Gorton GE; Nahorniak MT; Masso PD; Landry B; Lyman J; Sawicki R; Hagedorn K; Ross E; Warner J
J Pediatr Orthop; 2007 Jun; 27(4):451-6. PubMed ID: 17513969
[TBL] [Abstract][Full Text] [Related]
28. Botulinum toxin type A management of spasticity in the context of orthopaedic surgery for children with spastic cerebral palsy.
Graham HK
Eur J Neurol; 2001 Nov; 8 Suppl 5():30-9. PubMed ID: 11851732
[TBL] [Abstract][Full Text] [Related]
29. A randomized controlled trial to compare two botulinum toxin injection techniques on the functional improvement of the leg of children with cerebral palsy.
Kaishou Xu ; Tiebin Yan ; Jianning Mai
Clin Rehabil; 2009 Sep; 23(9):800-11. PubMed ID: 19482892
[TBL] [Abstract][Full Text] [Related]
30. Neurorehabilitation with versus without resistance training after botulinum toxin treatment in children with cerebral palsy: a randomized pilot study.
Bandholm T; Jensen BR; Nielsen LM; Rasmussen H; Bencke J; Curtis D; Pedersen SA; Sonne-Holm S
NeuroRehabilitation; 2012; 30(4):277-86. PubMed ID: 22672941
[TBL] [Abstract][Full Text] [Related]
31. Botulinum toxin a treatment in children with cerebral palsy: its effects on walking and energy expenditure.
Balaban B; Tok F; Tan AK; Matthews DJ
Am J Phys Med Rehabil; 2012 Jan; 91(1):53-64. PubMed ID: 22157436
[TBL] [Abstract][Full Text] [Related]
32. Double-blind study of botulinum A toxin injections into the gastrocnemius muscle in patients with cerebral palsy.
Sutherland DH; Kaufman KR; Wyatt MP; Chambers HG; Mubarak SJ
Gait Posture; 1999 Sep; 10(1):1-9. PubMed ID: 10469936
[TBL] [Abstract][Full Text] [Related]
33. Use of botulinum toxin type A in pediatric patients with cerebral palsy: a three-center retrospective chart review.
Gormley ME; Gaebler-Spira D; Delgado MR
J Child Neurol; 2001 Feb; 16(2):113-8. PubMed ID: 11292216
[TBL] [Abstract][Full Text] [Related]
34. Treatment of functional limitations at the knee in ambulatory children with cerebral palsy.
Chambers HG
Eur J Neurol; 2001 Nov; 8 Suppl 5():59-74. PubMed ID: 11851735
[TBL] [Abstract][Full Text] [Related]
35. Long lasting benefits following the combination of static night upper extremity splinting with botulinum toxin A injections in cerebral palsy children.
Kanellopoulos AD; Mavrogenis AF; Mitsiokapa EA; Panagopoulos D; Skouteli H; Vrettos SG; Tzanos G; Papagelopoulos PJ
Eur J Phys Rehabil Med; 2009 Dec; 45(4):501-6. PubMed ID: 20032908
[TBL] [Abstract][Full Text] [Related]
36. [Botulinum toxin A in the treatment of infantile cerebral palsy. Taking into account multilevel, integrated treatment].
Molenaers G; Desloovere K; De Cat J
Orthopade; 2004 Oct; 33(10):1119-28. PubMed ID: 15278274
[TBL] [Abstract][Full Text] [Related]
37. Botulinum toxin A does not improve the results of cast treatment for idiopathic toe-walking: a randomized controlled trial.
Engström P; Bartonek Å; Tedroff K; Orefelt C; Haglund-Åkerlind Y; Gutierrez-Farewik EM
J Bone Joint Surg Am; 2013 Mar; 95(5):400-7. PubMed ID: 23467862
[TBL] [Abstract][Full Text] [Related]
38. Use of botulinum toxin in the treatment of ankle plantar flexor spasticity in children with cerebral palsy.
Mirska A; Cybula K; Okurowska-Zawada B; Kułak W; Dmitruk E; Okulczyk K; Kalinowska AK
J Pediatr Orthop B; 2014 Nov; 23(6):517-22. PubMed ID: 25171568
[TBL] [Abstract][Full Text] [Related]
39. Botulinum toxin injections minimally affect modelled muscle forces during gait in children with cerebral palsy.
Wesseling M; Kainz H; Hoekstra T; Van Rossom S; Desloovere K; De Groote F; Jonkers I
Gait Posture; 2020 Oct; 82():54-60. PubMed ID: 32892101
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of group versus individual physiotherapy following lower limb intra-muscular Botulinum Toxin-Type A injections for ambulant children with cerebral palsy: A single-blind randomized comparison trial.
Thomas RE; Johnston LM; Sakzewski L; Kentish MJ; Boyd RN
Res Dev Disabil; 2016; 53-54():267-78. PubMed ID: 26955912
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
